Novavax stock forecast (NASDAQ: NVAX) – are investors buying now?

Novavax, Inc.(NASDAQ: NVAX) has seen an incredible year in stock price growth, increasing 307% over the past 12 months. The companies COVID-19 vaccine saw the market rally behind NVAX, posting a 52 week high in February of $331.68. The company announced yesterday that their COVID-19 vaccine NVX-CoV2373 demonstrated 100% protection against moderate and severe disease and a 90.4% efficacy overall in the Phase 3 trial.…